Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
1999 1
2002 1
2003 1
2006 1
2009 2
2012 1
2013 1
2014 4
2015 2
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Fecal immunochemical test accuracy in average-risk colorectal cancer screening.
Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, Castro I, de Castro L, Vega P, Hermo JA, Macenlle R, Martínez-Turnes A, Martínez-Ares D, Estevez P, Cid E, Vidal MC, López-Martínez A, Hijona E, Herreros-Villanueva M, Bujanda L, Rodriguez-Prada JI; COLONPREV Study Investigators. Hernandez V, et al. Among authors: hermo ja. World J Gastroenterol. 2014 Jan 28;20(4):1038-47. doi: 10.3748/wjg.v20.i4.1038. World J Gastroenterol. 2014. PMID: 24574776 Free PMC article.
Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening.
Cubiella J, Castro I, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, de-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Martínez-Ares D, Estevez P, Cid E, Herreros-Villanueva M, Portillo I, Bujanda L, Fernández-Seara J; COLONPREV study investigators. Cubiella J, et al. Among authors: hermo ja. Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1884-92. doi: 10.1158/1055-9965.EPI-13-1346. Epub 2014 Jun 24. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24962836
Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms.
Castro I, Estevez P, Cubiella J, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, de-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Cid E, Gil I, Larzabal M, Bujanda L, Castells A; COLONPREV study investigators. Castro I, et al. Among authors: hermo ja. Dig Dis Sci. 2015 May;60(5):1424-32. doi: 10.1007/s10620-014-3434-6. Epub 2014 Nov 19. Dig Dis Sci. 2015. PMID: 25407805
[Acute cholestatic hepatitis after atorvastatin reintroduction].
de Castro ML, Hermo JA, Baz A, de Luaces C, Pérez R, Clofent J. de Castro ML, et al. Among authors: hermo ja. Gastroenterol Hepatol. 2006 Jan;29(1):21-4. doi: 10.1157/13083248. Gastroenterol Hepatol. 2006. PMID: 16393626 Spanish.
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies.
Jover R, Zapater P, Polanía E, Bujanda L, Lanas A, Hermo JA, Cubiella J, Ono A, González-Méndez Y, Peris A, Pellisé M, Seoane A, Herreros-de-Tejada A, Ponce M, Marín-Gabriel JC, Chaparro M, Cacho G, Fernández-Díez S, Arenas J, Sopeña F, de-Castro L, Vega-Villaamil P, Rodríguez-Soler M, Carballo F, Salas D, Morillas JD, Andreu M, Quintero E, Castells A; COLONPREV study investigators. Jover R, et al. Among authors: hermo ja. Gastrointest Endosc. 2013 Mar;77(3):381-389.e1. doi: 10.1016/j.gie.2012.09.027. Epub 2012 Dec 4. Gastrointest Endosc. 2013. PMID: 23218945 Clinical Trial.
Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening.
Cubiella J, Castro I, Hernandez V, González-Mao C, Rivera C, Iglesias F, Alves MT, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Estevez P, Cid E, Herreros-Villanueva M, Portillo I, Bujanda L, Fernández-Seara J; COLONPREV study investigators. Cubiella J, et al. Among authors: hermo ja. United European Gastroenterol J. 2014 Dec;2(6):522-9. doi: 10.1177/2050640614553285. United European Gastroenterol J. 2014. PMID: 25452848 Free PMC article.
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.
Perelló C, Carrión JA, Ruiz-Antorán B, Crespo J, Turnes J, Llaneras J, Lens S, Delgado M, García-Samaniego J, García-Paredes F, Fernández I, Morillas RM, Rincón D, Porres JC, Prieto M, Lázaro Ríos M, Fernández-Rodríguez C, Hermo JA, Rodríguez M, Herrero JI, Ruiz P, Fernández JR, Macías M, Pascasio JM, Moreno JM, Serra MÁ, Arenas J, Real Y, Jorquera F, Calleja JL; Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Acting Drugs. Perelló C, et al. Among authors: hermo ja. J Viral Hepat. 2017 Mar;24(3):226-237. doi: 10.1111/jvh.12637. Epub 2016 Dec 15. J Viral Hepat. 2017. PMID: 27976491
16 results